Elisa Luqman compensation by year
Nutex Health Summary Compensation Table · all 2 fiscal years held| Component | FY2020 | FY2022 |
|---|---|---|
| Salary | $133,225 | $251,334 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $217,328 | $341,988 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $0 | $0 |
| Total | $350,553 | $593,322 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Nutex Health Inc. DEF 14A filed May 19, 2023, accession 0001104659-23-062628, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Nutex Health Inc. filed document, accession 0001104659-23-062628. Every figure is read from that document and cited to the page and table it appears in. Filed May 19, 2023.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 667,106 | — | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Nutex Health Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
6 Form 4 lines since the FY2022 proxy (filed May 19, 2023)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-03-10 | Tax withholding | — | 784 | $86.22 | 2,370 |
| 2026-03-10 | Exercise or conversion | — | 2,084 | $0.00 | 3,154 |
| 2026-03-10 | Exercise or conversion derivative | — | 1,525 | $0.00 | 4,441 |
| 2025-04-04 | Tax withholding | — | 266 | $72.10 | 1,070 |
| 2025-03-10 | Exercise or conversion derivative | — | 2,500 | $0.00 | 5,000 |
| 2025-03-01 | Exercise or conversion | — | 1,250 | $0.00 | 1,336 |
The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Nutex Health’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Warren Hosseinion | President | $2,672,078 |
| Thomas Vo | Chief Executive Officer | $938,225 |
| Michael Bowen | Chief Legal Officer | $642,600 |
| Elisa Luqman · this page | Chief Legal Officer – SEC | $593,322 |
| Pamela Montgomery | Chief Legal Officer | $275,355 |
| Jon Bates | Chief Financial Officer | $152,912 |
The full Nutex Health compensation record
free company briefThis page is one person within Nutex Health's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Nutex Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.